Category: Pharmaceutical Development
QR Codes on Drug Labels: Real-Time Safety Updates Explained
- By : Tamsin Riverton
- Date : Jul 7 2026
Discover how QR codes on drug labels enable real-time safety updates, replacing outdated paper leaflets with dynamic digital information to enhance patient safety and regulatory compliance.
GDUFA Explained: How User Fees Power FDA Generic Drug Reviews
- By : Tamsin Riverton
- Date : Jun 14 2026
Discover how GDUFA laws fund FDA generic drug reviews, speeding up access to affordable meds. Learn about fee structures, compliance, and the impact on manufacturers.
Hatch-Waxman Act Explained: How It Changed Generic Drug Prices and Patents
- By : Tamsin Riverton
- Date : Jun 9 2026
Discover how the Hatch-Waxman Act revolutionized the US pharmaceutical industry by balancing patent protection for innovators with accelerated approval for generic drugs, drastically lowering medication costs.
Combination Drug Substitution: Legal and Practical Challenges for Pharmacists
- By : Tamsin Riverton
- Date : May 3 2026
Explore the legal and practical challenges of combination drug substitution. Learn about fixed-dose combinations, therapeutic equivalence, state laws, and patient safety risks in pharmacy practice.
Quality by Design (QbD) in Generic Drug Development: Modern Science-Based Approaches
- By : Tamsin Riverton
- Date : Apr 5 2026
Explore how Quality by Design (QbD) transforms generic drug development from a 'copycat' method to a science-driven process that accelerates FDA ANDA approvals.
